Atrás
24
También listada como
SRHGF
OTC
Rango del Día
$16.12
$16.41
Rango de 52 Semanas
$12.69
$17.50
Volumen
9
Promedio 50D / 200D
$16.48
/
$16.13
Cierre Anterior
$15.77
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Consumer Cyclical (610 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 1.2 | 11.2 |
| P/B | 0.3 | 1.4 |
| ROE % | 26.2 | 10.7 |
| Net Margin % | 3.0 | 5.1 |
| Rev Growth 5Y % | 10.7 | 8.3 |
| D/E | 1.9 | 0.8 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$0.00
$0.00 – $0.00
|
300 B | 0 |
| FY2026 |
$0.00
$0.00 – $0.00
|
270 B | 0 |
Puntos Clave
Revenue grew 10.74% annually over 5 years — strong growth
Earnings grew 21.40% over the past year
ROE of 26.16% indicates high profitability
Generating 2.99B in free cash flow
P/E of 1.17 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.76%
Crecimiento
Revenue Growth (5Y)
10.74%
Revenue (1Y)4.98%
Earnings (1Y)21.40%
FCF Growth (3Y)-2.22%
Calidad
Return on Equity
26.16%
ROIC13.02%
Net Margin3.00%
Op. Margin5.91%
Seguridad
Debt / Equity
1.85
Current Ratio1.19
Interest Coverage2.92
Valoración
P/E Ratio
1.17
P/B Ratio0.30
EV/EBITDA3.67
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.98% | Revenue Growth (3Y) | 8.42% |
| Earnings Growth (1Y) | 21.40% | Earnings Growth (3Y) | 13.52% |
| Revenue Growth (5Y) | 10.74% | Earnings Growth (5Y) | 11.88% |
| Profitability | |||
| Revenue (TTM) | 252.70B | Net Income (TTM) | 7.59B |
| ROE | 26.16% | ROA | 6.07% |
| Gross Margin | 24.31% | Operating Margin | 5.91% |
| Net Margin | 3.00% | Free Cash Flow (TTM) | 2.99B |
| ROIC | 13.02% | FCF Growth (3Y) | -2.22% |
| Safety | |||
| Debt / Equity | 1.85 | Current Ratio | 1.19 |
| Interest Coverage | 2.92 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 1.17 | P/B Ratio | 0.30 |
| P/S Ratio | 0.04 | PEG Ratio | 1.61 |
| EV/EBITDA | 3.67 | Dividend Yield | 0.02% |
| Market Cap | 8.91B | Enterprise Value | 54.84B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 252.70B | 240.72B | 214.96B | 184.08B | 168.03B |
| Net Income | 7.59B | 6.25B | 5.89B | 5.71B | 4.84B |
| EPS (Diluted) | 13.93 | 11.44 | 10.78 | 10.44 | 8.74 |
| Gross Profit | 61.44B | 54.82B | 51.71B | 45.06B | 41.21B |
| Operating Income | 14.94B | 13.16B | 12.34B | 10.81B | 9.66B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 124.94B | 112.33B | 102.36B | 91.46B | 77.07B |
| Total Liabilities | 94.83B | 84.60B | 76.08B | 65.83B | 55.86B |
| Shareholders' Equity | 30.19B | 27.79B | 26.13B | 25.48B | 21.08B |
| Total Debt | 55.88B | 49.37B | 48.55B | 42.13B | 34.22B |
| Cash & Equivalents | 9.95B | 11.73B | 12.55B | 10.67B | 7.95B |
| Current Assets | 52.87B | 50.06B | 47.87B | 39.67B | 32.06B |
| Current Liabilities | 44.54B | 41.54B | 37.42B | 32.49B | 28.29B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#386 of 670
Actividad Reciente
Entró
Contrarian Investing (David Dreman)
Mar 24, 2026